Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
Pathways to Success for MedTech Innovators
View Registrations Tell a Friend About This EventTell a Friend

PATHWAYS TO SUCCESS FOR MEDTECH INNOVATORS -- This forum will bring together a diverse and experienced panel to discuss strategies for startup conception, funding, development and partnership.

When: May 2, 2019
4:00 - 7:00 PM
Where: Nutter McClennen & Fish LLP
155 Seaport Blvd
Boston, Massachusetts  02210
United States
Contact: Bill Munger

Online registration is closed.
« Go to Upcoming Event List  

Pathways to Success for
MedTech Innovators - May 2 - Thursday

Meet Laura Indolfi, Co-Founder and CEO of PanTher Therapeutics,
developing a combination device-drug product for localized cancer treatment. She will share her company creation
story, which the panel will use as a
case study. Laura was named a
TED fellow and a winner of the MLSC MassNextGen Initiative to support women entrepreneurs.

This panel will include an experienced entrepreneur, investor, market strategy consultant, and large company representative to present and discuss pathways to success, from startup conception, funding, and development to strategic partnership.

A tremendous opportunity for healthcare innovation.has been created through the combination of scientific advances in the understanding of diseases and the human body, along with the technological advances. 

Turning an idea into a product isn't easy in any industry. The MedTech industry innovators face challenges in meeting regulatory requirements, proving safety and efficacy and determining who is going to pay for their product.

To translate a great idea into a viable business, entrepreneurs are challenged to create an IP portfolio, build a credible team, provide compelling data that their product works, and understand the unmet need, competitive landscape and market.

The Pathways to Success Involve Strategies
for Startup Conception, Funding,
Development and Partnership.

Registration, Meet Exhibitors, Networking
Presentations, Panel and Q&A
Talk to Exhibitors and Networking
with Food and Beverages

Event Sponsors

May 2 Thursday
4:00 - 7:00 PM
Nutter McClennen & Fish LLP 
155 Seaport Blvd, Boston 

Event Sponsorship - $500  
 (contact Hank Allard for details 

Who Should Attend: 
  • Medical Development Entrepreneurs
  • Physicians interested in the process of bringing products to market
  • Medical Technology professionals interested in broadening their knowledge and perspective
  • Entrepreneurs interested in fund raising and partnership solutions
  • Organizations looking to serve the needs of Entrepreneurs
Our Distinguished Panel
Co-Founder, President & CEO, AltrixBio
Ibraheem Badejo, PhD
Senior Director - New Ventures (Med Devices) Johnson & Johnson Innovation Center, Boston
Darshana Zaveri,MPA
Partner at Catalyst Ventures
Ilsa Webeck, MBA 
Principal, MedTech Strategies
Laura Indolfi 
Co-Founder & CEO
PanTher Therapeutics
Panel Bios
Nancy Briefs, MBA
Co-Founder, President & CEO, AltrixBio
Strategic business leader with extensive experience creating value, driving strategy and launching product commercialization in diverse life science companies. Deep general management and fundraising expertise having raised over $500 M in equity including IPO. Innovative, collaborative and entrepreneurial, strong communicator and tenacious. Trusted advisor and mentor to founders and boards.

Energized by turning innovation into commercial reality, working with creative scientists, and communicating value to partners and investors. Extensive regulatory experience with FDA and notified bodies. Nancy is currently on the Board for Digital Cognition Technologies, Inc., MyndBlue, and Health Helm, Inc.

Ibraheem Badejo, PhD
Senior Director - New Ventures (Med Devices) Johnson & Johnson Innovation Center, Boston
Ibraheem (Ib) leverages his expertise in smart materials and biomaterials to support the medical device sector of Johnson & Johnson. From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials.

Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by Johnson & Johnson in 2005). Ib has held various positions at Bayer, North Carolina State University, and the College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University. During his career, Ibraheem has led teams in the development of commercialized biomaterials- based products and new technology / products licensed or acquired.

Darshana Zaveri,MPA
Partner at Catalyst Ventures
Darshana is actively involved in all aspects of Fund Management including Investments and Capital Raising. She led Catalyst's investments in Augmenix, Lantos Technologies, nVision Medical, Maxwell Health, Aria CV and Hepregen. She currently represents Catalyst on the Boards of Lantos (past Chair), nVision, Aria CV, Augmenix and Maxwell Health and is actively involved with portfolio company Allegro Diagnostics.  
Darshana brings to Catalyst over a decade of experience in the health care and Life Science Industries. Prior to Catalyst, she was an Investigator at Vertex Pharmaceuticals and an integral part of the drug development programs in oncology, metabolic disease, and immunology.
Ilsa Webeck, MBA  
Principal, MedTech Strategies
Ilsa Webeck founded MedTech Strategies, a boutique, strategic research consulting firm, with the knowledge that all companies, regardless of their size, need to develop a product/service value proposition and understand the business of healthcare in order to be successful.  
She works with companies on new technology initiatives focused on identifying value and actionable outcomes for growth. Her past roles include corporate planning, product management and early product strategy at Johnson & Johnson's DePuy Spine, Biogen and Health Advances. Ilsa holds an MBA from the Tuck School of Business and a BA in Biology from Dartmouth College. She is an invited lecturer at the Boston Biomedical Innovation Center and is a member of the MDG board.

Laura Indolfi  
Co-Founder & CEO of PanTher Therapeutics
PanTher Therapeutics is an early stage spin-out from MIT and MGH that provides superior technologies for revolutionizing the treatment of locally advanced inoperable solid tumors.
Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledge to drive the company's vision. She strongly believes in the power of outreaching initiatives to promote research awareness and foster the public audiences discovery of the beauty of science
Paul Hartung 
Board Director
MDG, Leuko,
Joshua Franklin 
Financial Advisor
Merrill Lynch
Kristofer Munroe
Dir Market Access General Counsel Argenta Advisors
Fees -  (Light dinner included)
Fee Category Early Registration
(By April 25)
Week Prior
(April 25 - May 2)

At the Door
(May 2
Member/Alliance Partner: $30 $35 $45
Non-Member: $45 $55 $65
Student Member $10 $12 $15    
Student Non-member w/ a valid ID $15 $18 $20 
Gold Member No Charge No Charge  No Charge 
Event Sponsor - $500
Contact Hank Allard for details

more MDG Calendar

Cutting Edge Advances in Auditory Device Therapies

Annual Holiday Party

Software as a Medical Device (SaMD)

MDG Premium & Annual Sponsors


 Medical Development  Group
 POB 555
 Concord, MA 01742







 About Us
 Terms of Use
 Privacy Policy







Association Management Software Powered by YourMembership  ::  Legal